In fact, a study published in 2019 successfully demonstrated that “a long‐term anti-TNF-alpha therapy in patients with IBD reduces aortic pulse‐wave velocity to a level comparable to that of healthy individuals” [9]. The gene discussed is TNF; the disease is inflammatory bowel disease.